TABLE OF CONTENTS
|  | | | | Volume 117, Issue 12 (1733-1887)
Published online 5 December 2017
|  | In this issue
 Editorial
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Also new today
 Advance online publication
Digital Edition
| | | Editorial | Top | | IGF-1R: SUMO-ing its weight in chemoresistant colorectal cancer Ajay Goel Br J Cancer 2017 117: 1733-1735; advance online publication, November 9, 2017; 10.1038/bjc.2017.377 Full Text | | Minireview | Top | | Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required? Alexander H Staudacher and Michael P Brown Br J Cancer 2017 117: 1736-1742; advance online publication, October 24, 2017; 10.1038/bjc.2017.367 Abstract | Full Text | | Clinical Studies | Top | | Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review A Prawira, S F Oosting, T W Chen, K A delos Santos, R Saluja, L Wang, L L Siu, K K W Chan and A R Hansen Br J Cancer 2017 117: 1743-1752; advance online publication, October 24, 2017; 10.1038/bjc.2017.357 Abstract | Full Text | | | | Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer An Na Seo, Byung Woog Kang, Oh Kyoung Kwon, Ki Bum Park, Seung Soo Lee, Ho Young Chung, Wansik Yu, Han Ik Bae, Seong Woo Jeon, Hyojeung Kang and Jong Gwang Kim Br J Cancer 2017 117: 1753-1760; advance online publication, October 26, 2017; 10.1038/bjc.2017.369 Abstract | Full Text | | | | Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions A Albuquerque, H Pessegueiro Miranda, J Lopes, J Gandara, S Rodrigues, R Gaspar, R Morais, R Ramalho, E Rodrigues-Pinto, H Cardoso, H Barroca, C C Dias, F Carneiro and G Macedo Br J Cancer 2017 117: 1761-1767; advance online publication, October 31, 2017; 10.1038/bjc.2017.370 Abstract | Full Text | | | | Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials Kaitlyn K H Goey, Sjoerd G Elias, Axel Hinke, Martijn G H van Oijen, Cornelis J A Punt, Susanna Hegewisch-Becker, Dirk Arnold and Miriam Koopman Br J Cancer 2017 117: 1768-1776; advance online publication, November 9, 2017; 10.1038/bjc.2017.382 Abstract | Full Text | | Translational Therapeutics | Top | | Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer Jordi Codony-Servat, Miriam Cuatrecasas, Elena Asensio, Carla Montironi, Anna Martínez-Cardús, Mercedes Marín-Aguilera, Carlos Horndler, Eva Martínez-Balibrea, Michele Rubini, Pedro Jares, Oscar Reig, Iván Victoria, Lydia Gaba, Marta Martín-Richard, Vicente Alonso, Pilar Escudero, Carlos Fernández-Martos, Jaime Feliu, Jose Carlos Méndez, Miguel Méndez, Javier Gallego, Antonieta Salud, Federico Rojo, Antoni Castells, Aleix Prat, Rafael Rosell, Xabier García-Albéniz, Jordi Camps and Joan Maurel Br J Cancer 2017 117: 1777-1786; advance online publication, November 9, 2017; 10.1038/bjc.2017.279 Abstract | Full Text | | | | Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma Carmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, Fréderic Chibon, Isabelle Treilleux, Jean-Michel Coindre, Pierre Meeus, Mehdi Brahmi, Olivia Bally, Isabelle Ray-Coquard, Marie-Pierre Sunyach, Axel Le Cesne, Olivier Mir, Sylvie Bonvalot, Maud Toulmonde, Antoine Italiano, Pierre Saintigny, Myriam Jean-Denis, Francoise Ducimetiere, Dominique Ranchere, Hiba El Sayadi, Laurent Alberti and Jean-Yves Blay Br J Cancer 2017 117: 1787-1797; advance online publication, October 12, 2017; 10.1038/bjc.2017.354 Abstract | Full Text | | | | ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer Ikhyun Jun, Hyung Soon Park, He Piao, Jung Woo Han, Min Ji An, Byeong Gyu Yun, Xianglan Zhang, Yong Hoon Cha, You Keun Shin, Jong In Yook, Jinsei Jung, Heon Yung Gee, Joon Seong Park, Dong Sup Yoon, Hei-Cheul Jeung and Min Goo Lee Br J Cancer 2017 117: 1798-1809; advance online publication, October 12, 2017; 10.1038/bjc.2017.355 Abstract | Full Text | | | | Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma Woo Jin Bae, Bon Seok Koo, Sang Hyuk Lee, Jin Man Kim, Young Soo Rho, Jae Yol Lim, Jung Hwa Moon, Jae Hoon Cho and Young Chang Lim Br J Cancer 2017 117: 1810-1818; advance online publication, November 2, 2017; 10.1038/bjc.2017.373 Abstract | Full Text | | Molecular Diagnostics | Top | | Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma Astrid Lièvre, Bérèngere Ouine, Jim Canet, Aurélie Cartier, Yael Amar, Wulfran Cacheux, Odette Mariani, Rosine Guimbaud, Janick Selves, Thierry Lecomte, Serge Guyetant, Ivan Bieche, Frédérique Berger and Leanne de Koning Br J Cancer 2017 117: 1819-1827; advance online publication, October 12, 2017; 10.1038/bjc.2017.353 Abstract | Full Text | | | | Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion Ching-Fang Yu, Fang-Hsin Chen, Meng-Hsuan Lu, Ji-Hong Hong and Chi-Shiun Chiang Br J Cancer 2017 117: 1828-1836; advance online publication, October 24, 2017; 10.1038/bjc.2017.362 Abstract | Full Text | | | | CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma Thomas A Werner, Christina M Forster, Levent Dizdar, Pablo E Verde, Katharina Raba, Matthias Schott, Wolfram T Knoefel and Andreas Krieg Br J Cancer 2017 117: 1837-1845; advance online publication, November 7, 2017; 10.1038/bjc.2017.364 Abstract | Full Text | | | | A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline Xiaohui Liu, Weimin Zheng, Wansheng Wang, Huali Shen, Linxiao Liu, Wenhui Lou, Xiaolin Wang and Pengyuan Yang Br J Cancer 2017 117: 1846-1854; advance online publication, November 9, 2017; 10.1038/bjc.2017.365 Abstract | Full Text | | Genetics & Genomics | Top | | Global metabolomic profiling of uterine leiomyomas Hanna-Riikka Heinonen, Miika Mehine, Netta Mäkinen, Annukka Pasanen, Esa Pitkänen, Auli Karhu, Nanna S Sarvilinna, Jari Sjöberg, Oskari Heikinheimo, Ralf Bützow, Lauri A Aaltonen and Eevi Kaasinen Br J Cancer 2017 117: 1855-1864; advance online publication, October 26, 2017; 10.1038/bjc.2017.361 Abstract | Full Text | | Epidemiology | Top | | Cancer incidence in English children, adolescents and young people: past trends and projections to 2030 Francesca Pesola, Jacques Ferlay and Peter Sasieni Br J Cancer 2017 117: 1865-1873; advance online publication, November 2, 2017; 10.1038/bjc.2017.341 Abstract | Full Text | | | | Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival Vicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Justin L Bui, Chen Yuan, Zhi Rong Qian, Ana Babic, Annacarolina Da Silva, Jonathan A Nowak, Natalia Khalaf, Lauren K Brais, Marisa W Welch, Caitlin L Zellers, Kimmie Ng, Daniel T Chang, Rebecca A Miksad, Andrea J Bullock, Jennifer F Tseng, Richard S Swanson, Thomas E Clancy, David C Linehan, Jennifer J Findeis-Hosey, Leona A Doyle, Jason L Hornick, Shuji Ogino, Charles S Fuchs, Aram F Hezel, Albert C Koong and Brian M Wolpin Br J Cancer 2017 117: 1874-1882; advance online publication, October 5, 2017; 10.1038/bjc.2017.349 Abstract | Full Text | | | | 30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure Wan-Hua Hsieh, I-Feng Lin, Jung-Chun Ho and Peter Wushou Chang Br J Cancer 2017 117: 1883-1887; advance online publication, October 3, 2017; 10.1038/bjc.2017.350 Abstract | Full Text | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment